BPC-157 + TB-500 Research Blend — Research Consultation
A combined-blend research preparation of BPC-157 (a pentadecapeptide derived from a gastric protective sequence) and TB-500 (a thymosin β4 actin-binding fragment). Published research describes the two compounds acting through largely independent pathways, making the blend a useful research tool for studying combined tissue-recovery signalling.
What this blend is
The combined research preparation pairs BPC-157 (Body Protective Compound, 15 amino acids) with TB-500 (a 17-amino-acid synthetic fragment from the actin-binding region of thymosin β4). Both component molecules have their own established preclinical research bases. The blend is supplied as a single lyophilised research preparation for protocols studying the two compounds simultaneously.
Independent-pathway research model
Published research describes BPC-157 and TB-500 acting through largely independent mechanisms. BPC-157 is associated with growth-factor expression, angiogenesis signalling, and gut-barrier integrity. TB-500 is associated with actin sequestration, cell-migration signalling, and inflammatory-pathway interactions. The research argument for the blend is that the two pathways may be additive in tissue-recovery research models.
Quality verification
Lyophilised blend manufactured under ICH Q7 GMP standards. Independent HPLC verification at a US-based third-party laboratory confirms peak-area purity of both peptides individually. COA available through the in-chat consultation.
Common research questions
- Is the BPC-157 + TB-500 blend legal in the UAE?
- Both component peptides are classified as research compounds in the UAE and are sold through standard wellness-supply channels with VAT compliance applied to every dispatch.
- What dose ranges does the published research describe?
- Grey-research protocols commonly describe 200-500 mcg of each peptide per administration, two-to-three times weekly, in cycles of 4-8 weeks. The blend allows both compounds to be drawn in a single injection. No consensus optimal protocol exists in published human research.
- Blend vs. separate?
- BPC-157 and TB-500 are sold separately for researchers studying single-pathway questions. The blend is for researchers studying combined-pathway tissue-recovery research. The blend formulation is the same total peptide content as buying both separately, in one bottle.
- How is purity verified?
- HPLC peak-area purity (≥98%) at a US-based third-party laboratory for both peptides. COA available through the chat.
- Shelf life and storage?
- Lyophilised powder is ambient-temperature stable in transit; -20°C long-term storage; refrigerated post-reconstitution per the supplied protocol.
- How fast is delivery in the UAE?
- Same-day delivery within Dubai, next-business-day across the rest of the UAE.
- Can I ask Nour about the difference between the blend and the components?
- Yes. Tap "Start a research consultation". Nour can walk through which protocol — single-pathway or combined-pathway — best fits your research question.
Peer-reviewed references
Related consultations
Talk to Nour about your research protocol
Nour reads the peer-reviewed literature and walks you through what each compound is best suited for. English or Arabic, inside the chat.